Solaris Resources (CVE:SLS) Shares Down 2.7%

Solaris Resources Inc. (CVE:SLSGet Rating) was down 2.7% during trading on Tuesday . The stock traded as low as C$5.95 and last traded at C$6.15. Approximately 53,313 shares traded hands during trading, a decline of 60% from the average daily volume of 132,199 shares. The stock had previously closed at C$6.32.

Solaris Resources Price Performance

The firm has a fifty day simple moving average of C$6.15.

Solaris Resources (CVE:SLSGet Rating) last issued its quarterly earnings data on Tuesday, August 9th. The company reported C($0.18) earnings per share (EPS) for the quarter.

Solaris Resources Company Profile

(Get Rating)

SELLAS is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapeutics for a broad range of cancer indications. SELLAS’ lead product candidate, GPS, is licensed from Memorial Sloan Kettering Cancer Center and targets the WT1 protein, which is present in an array of tumor types.

Recommended Stories

Receive News & Ratings for Solaris Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solaris Resources and related companies with's FREE daily email newsletter.